Revvity broadens relationship with Genomics England to advance genomics in the UK

Collaborating for better baby health

22-Nov-2024 - Revvity, Inc. announced an expansion of its work with Genomics England that leverages both organizations' expertise and resources to advance critical genomic initiatives across the United Kingdom. Building on the parties’ long and productive work history, this advanced collaboration is dedicated ...

Cracking the code of life: New AI model deciphers the hidden language of DNA

07-Aug-2024 - Scientists at TU Dresden have trained a large language model with human DNA. Researchers can use it to try to decode the complex information hidden in our genome. The AI treats human DNA like language, learning its rules and relationships to derive functional information about the DNA sequences. ...

Scientists use quantum biology, AI to sharpen genome editing tool

"This study represents an exciting advancement toward, understanding how we can avoid making costly ‘typos’ in an organism’s genetic code"

21-Nov-2023 - Scientists at Oak Ridge National Laboratory used their expertise in quantum biology, artificial intelligence and bioengineering to improve how CRISPR Cas9 genome editing tools work on organisms like microbes that can be modified to produce renewable fuels and chemicals. CRISPR is a powerful tool ...

INTEGRA Biosciences acquires start-up Miroculus to accelerate genomics

20-Mar-2023 - INTEGRA Biosciences announced that it has acquired Miroculus, a biotechnology specialist focused on developing hands-off automation solutions for next generation sequencing (NGS) protocols. This will allow INTEGRA to expand its product range for library preparation, offering significant time ...

Start-up wants to bring extinct bird back to life

Colossal Biosciences Secures $150M Series B

02-Feb-2023 - Colossal Biosciences, the world’s first de-extinction company, has announced an oversubscribed $150M Series B financing led by United States Innovative Technology Fund (USIT), with participation from Breyer Capital, WestRiver Group, Bob Nelsen, Animal Capital, Victor Vescovo, In-Q-Tel, Animoca ...

Superworms capable of munching through plastic waste

The long-term goal is to engineer enzymes to degrade plastic waste

14-Jun-2022 - Researchers at the University of Queensland have found a species of worm with an appetite for polystyrene could be the key to plastic recycling on a mass scale. Scientists discovered the commonZophobas morio‘superworm’ can eat through polystyrene, thanks to a bacterial enzyme in their gut. Dr ...

Cyanobacteria: Small candidates as great hopes for medicine and biotechnology

27-Oct-2020 - In order to unlock the genetic potential of unusual cyanobacteria for the production of new active agents and to explore the potential for applications in biotechnology, the team headed by Dr Paul D'Agostino has been awarded a competitive whole-genome sequencing grant from the Joint Genome ...

Machine learning to identify source of Salmonella

Quick identification of animal source key to stopping foodborne illness outbreaks

13-Feb-2019 - A team of scientists led by researchers at the University of Georgia Center for Food Safety in Griffin has developed a machine-learning approach that could lead to quicker identification of the animal source of certain Salmonella outbreaks. In the research, Xiangyu Deng and his colleagues used ...

QIAGEN acquires bioinformatics company

Expanding clinical bioinformatics capabilities in molecular oncology

08-Jan-2019 - QIAGEN N.V. announced it has entered into an agreement to acquire N-of-One, Inc., a privately-held U.S. molecular decision support company and pioneer in clinical interpretation services for complex genomic data. The addition of N-of-One will enable QIAGEN to significantly expand its ...

Elevated hormone flags liver problems in mice with methylmalonic acidemia

Study findings can immediately be applied to human patients with the disease

11-Dec-2018 - Researchers have discovered that a hormone, fibroblast growth factor 21 (FGF21), is extremely elevated in mice with liver disease that mimics the same condition in patients with methylmalonic acidemia (MMA), a serious genomic disorder. Based on this finding, medical teams treating patients with ...